Congress Incentivizes Rare Disease Research. Big Pharma Exploits It. – Mother Jones
Loopholes in the Orphan Drug Act serve drug companies, not patients.
Source: motherjones.com
Stay updated with breaking news from Eric Sid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Loopholes in the Orphan Drug Act serve drug companies, not patients.